Imaging outcome measures for progressive multiple sclerosis trials (vol 23, pg 1614, 2017)

被引：0
|
作者：
Moccia, M.
De Stefano, N.
Barkhof, F.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 02期
关键词：
D O I：
10.1177/1352458517746321
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：NP32 / NP32
页数：1
相关论文
共 50 条
  • [1] Imaging outcome measures for progressive multiple sclerosis trials
    Moccia, Marcello
    de Stefano, Nicola
    Barkhof, Frederik
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1614 - 1626
  • [2] Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis (vol 23, pg 1, 2017)
    Cawley, N.
    Tur, C.
    Prados, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP30 - NP30
  • [3] Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Uitdehaag, Bernard
    Cutter, Gary
    NEUROLOGY, 2021, 96 (01) : E111 - E120
  • [4] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [5] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
  • [6] Outcome Measures in Clinical Trials for Multiple Sclerosis
    van Munster, Caspar E. P.
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2017, 31 (03) : 217 - 236
  • [7] Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis
    Altmann, Dan
    Jasperse, B.
    Barkhof, Frederik
    Beckmann, Karola
    Filippi, Massimo
    Kappos, Ludwig
    Molyneux, P.
    Polman, Chris H.
    Pozzilli, Carlo
    Thompson, Alan J.
    Wagner, Klaus
    Yousry, Tarek
    Miller, David H.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S22 - S22
  • [8] Cerebellar volume as imaging outcome in progressive multiple sclerosis
    Inglese, Matilde
    Petracca, Maria
    Mormina, Enricomaria
    Achiron, Anat
    Straus-Farber, Rebecca
    Miron, Shmuel
    Fabian, Michelle
    Krieger, Stephen
    Miller, Aaron
    Lublin, Fred
    Sormani, Maria Pia
    PLOS ONE, 2017, 12 (04):
  • [9] Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis (vol 23, pg 596, 2017)
    Kalincik, T.
    Jokubaitis, V
    Spelman, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14)
  • [10] Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
    Noble, J. Gareth
    Osborne, Lisa A.
    Jones, Kerina H.
    Middleton, Rod M.
    Ford, David V.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1718 - 1720
12345